Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery

This study has been completed.
OMRIX Biopharmaceuticals
Information provided by:
Ethicon, Inc. Identifier:
First received: March 23, 2006
Last updated: January 8, 2009
Last verified: January 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)